Notice2022-04273
National Cancer Institute; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 1, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 40 (Tuesday, March 1, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 40 (Tuesday, March 1, 2022)]
[Notices]
[Pages 11452-11453]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-04273]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Research Projects in Cancer Systems Biology (CSBC Research
Projects) (U01).
Date: March 31, 2022.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W234, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Adriana Stoica, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, 7W234, Rockville, Maryland 20850, 240-276-6368,
<a href="/cdn-cgi/l/email-protection#8bd8ffe4e2e8eaeab9cbe6eae2e7a5e5e2e3a5ece4fd"><span class="__cf_email__" data-cfemail="bdeec9d2d4dedcdc8ffdd0dcd4d193d3d4d593dad2cb">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-1 NCI Clinical and Translational R21 and Omnibus R03
Review.
Date: March 31, 2022.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W602, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Delia Tang, M.D., Scientific Review Officer,
Resources Training and Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W602, Rockville, Maryland 20850, 240-276-6456,
<a href="/cdn-cgi/l/email-protection#483c29262f2c082529212466262120662f273e"><span class="__cf_email__" data-cfemail="a4d0c5cac3c0e4c9c5cdc88acacdcc8ac3cbd2">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Social and Behavioral Intervention Research to Address
Modifiable Risk Factors for Cancer in Rural Populations (R01).
Date: May 5, 2022.
Time: 10:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room
[[Page 11453]]
7W618, Rockville, Maryland 20850 (Telephone Conference Call).
Contact Person: Mukesh Kumar, Ph.D., Scientific Review Officer,
Research Program Review Branch, Division of Extramural Activities,
9609 Medical Center Drive, Room 7W618, National Cancer Institute,
NIH, Rockville, Maryland 20850, 240-276-6611, <a href="/cdn-cgi/l/email-protection#fe938b959b8d96d0958b939f8ccdbe909796d0999188"><span class="__cf_email__" data-cfemail="701d051b1503185e1b051d110243301e19185e171f06">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: February 24, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-04273 Filed 2-28-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 1, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.